Abstract
The last years showed the rise of CRISPR/Cas9 to stardom. Several features such as programmability, specificity, and efficiency, make it to be a technique of choice for genome editing even in processes where basic aspects are not understood. However, scientific, technical and society driven challenges remain. To cope with these challenges, further research, technological improvements, translational studies as well as an open exchange between laboratories and the society are required.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Literatur
Ishino Y, Shinagawa H, Makino K et al. (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169:5429–5433
Haft DH, Selengut J, Mongodin EF et al. (2005) A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput Biol 1:e60
Mojica FJ, Diez-Villasenor C, Garcia-Martinez J et al. (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60:174–182
Pourcel C, Salvignol G, Vergnaud G (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151:653–663
Barrangou R, Fremaux C, Deveau H et al. (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709–1712
Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096
Deltcheva E, Chylinski K, Sharma CM et al. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471:602–607
Sternberg SH, Redding S, Jinek M et al. (2014) DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507:62–67
Jinek M, Chylinski K, Fonfara I et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821
Wright AV, Nunez JK, Doudna JA (2016) Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell 164:29–44
Mali P, Yang L, Esvelt KM et al. (2013) RNA-guided human genome engineering via Cas9. Science 339:823–826
Yang H, Wang H, Shivalila CS et al. (2013) One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154:1370–1379
Ihry RJ, Worringer KA, Salick MR et al. (2018) p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med 24:939–946
Haapaniemi E, Botla S, Persson J et al. (2018) CRISPRCas9 genome editing induces a p53-mediated DNA damage response. Nat Med 24:927–930
Kosicki M, Tomberg K, Bradley A (2018) Repair of double- strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol 36:765–771
Liang P, Xu Y, Zhang X et al. (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6:363–372
Ma H, Marti-Gutierrez N, Park SW et al. (2017) Correction of a pathogenic gene mutation in human embryos. Nature 548:413–419
Author information
Authors and Affiliations
Corresponding author
Additional information
Elitsa Dimova Biologie- und Ökologiestudium in Sofia, Bulgarien. 1997 Master of Science. 2005 Promotion an der Universität Göttingen. 2005–2009 Postdoc an der Fakultät für Chemie, TU Kaiserslautern. Seit 2017 Dozentin an der Fakultät für Biochemie und Molekulare Medizin, Universität Oulu, Finnland.
Thomas Kietzmann Medizinstudium in Greifswald, 1989 Diplom in Biochemie. 1989–1991 UNESCOStipendium. 1992 Promotion in Medizinischer Genetik. 1996 Facharzt für Biochemie. 2001 Habilitation am Institut für Biochemie und Molekulare Zellbiologie der Uni - versität Göttingen. 2004–2009 Professor für Biochemie, Fakultät für Chemie, TU Kaisers lautern. Seit 2009 Professor für zelluläre Biochemie an der Fakultät für Biochemie und Molekulare Medizin, Universität Oulu, Finnland.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaption, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Dimova, E.Y., Kietzmann, T. Genomveränderungen–CRISPR/Cas9 als Methode der Wahl oder Qual?. Biospektrum 24, 701–703 (2018). https://doi.org/10.1007/s12268-018-0977-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-018-0977-7